CoChat

High-fat diet exacerbates cognitive decline in mouse models of Alzheimer's disease and mixed dementia in a sex-dependent manner

Open access

Published version of a preprint

The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.

Abstract

Background: Approximately 70% of Alzheimer’s disease (AD) patients have co-morbid vascular contributions to cognitive impairment and dementia (VCID); this highly prevalent overlap of dementia subtypes is known as mixed dementia (MxD). AD is more prevalent in women, while VCID is slightly more prevalent in men. Sex differences in risk factors may contribute to sex differences in dementia subtypes. Unlike metabolically healthy women, diabetic women are more likely to develop VCID than diabetic men. Prediabetes is 3× more prevalent than diabetes and is linked to earlier onset of dementia in women, but not men. How prediabetes influences underlying pathology and cognitive outcomes across different dementia subtypes is unknown. To fill this gap in knowledge, we investigated the impact of diet-induced prediabetes and biological sex on cognitive function and neuropathology in mouse models of AD and MxD. Methods: Male and female 3xTg-AD mice received a sham (AD model) or unilateral common carotid artery occlusion surgery to induce chronic cerebral hypoperfusion (MxD model). Mice were fed a control or high fat (HF; 60% fat) diet from 3 to 7 months of age. In both sexes, HF diet elicited a prediabetic phenotype (impaired glucose tolerance) and weight gain. Results: In females, but not males, metabolic consequences of a HF diet were more severe in AD or MxD mice compared to WT. In both sexes, HF-fed AD or MxD mice displayed deficits in spatial memory in the Morris water maze (MWM). In females, but not males, HF-fed AD and MxD mice also displayed impaired spatial learning in the MWM. In females, but not males, AD or MxD caused deficits in activities of daily living, regardless of diet. Astrogliosis was more severe in AD and MxD females compared to males. Further, AD/MxD females had more amyloid beta plaques and hippocampal levels of insoluble amyloid beta 40 and 42 than AD/MxD males. In females, but not males, more severe glucose intolerance (prediabetes) was correlated with increased hippocampal microgliosis. Conclusions: High-fat diet had a wider array of metabolic, cognitive, and neuropathological consequences in AD and MxD females compared to males. These findings shed light on potential underlying mechanisms by which prediabetes may lead to earlier dementia onset in women.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12974-022-02466-2

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 HF diet caused greater metabolic impairment in AD and MxD females compared to males. A Experimental timeline. GTT (glucose tolerance test). B Weight gain was assessed by the % change in body weight from the start of the study to the end of the study. C Visceral adiposity was determined by isolating and weighing the visceral fat pads and normalizing to body weight. D, E Glucose intolerance was assessed with a GTT following a 16 h fast. D Glucose clearance was gauged by concentrations of glucose in the blood measured over time (time 0 = fasting blood glucose). E Blood glucose concentration over time was used to calculate area under the curve. We previously reported metabolic data for the Sham WT and Sham AD, but not the MxD, groups in Robison et al. (2020) in the Journal of Neuroinflammation [29]; licensed under a Creative Commons Attribution 4.0 International License; (https://creativecommons.org/licenses/by/4.0/). Data are presented as mean + SEM, **p < 0.01 effect of diet, ****p < 0.0001 effect of diet, ^p < 0.05 effect of dementia, ^^^p < 0.001 effect of dementia, ^^^^p < 0.0001 effect of dementia, 2-way ANOVA, (n = 13–25/group)
Fig. 1 HF diet caused greater metabolic impairment in AD and MxD females compared to males. A Experimental timeline. GTT (glucose tolerance test). B Weight gain was assessed by the % change in body weight from the start of the study to the end of the study. C Visceral adiposity was determined by isolating and weighing the visceral fat pads and normalizing to body weight. D, E Glucose intolerance was assessed with a GTT following a 16 h fast. D Glucose clearance was gauged by concentrations of glucose in the blood measured over time (time 0 = fasting blood glucose). E Blood glucose concentration over time was used to calculate area under the curve. We previously reported metabolic data for the Sham WT and Sham AD, but not the MxD, groups in Robison et al. (2020) in the Journal of Neuroinflammation [29]; licensed under a Creative Commons Attribution 4.0 International License; (https://creativecommons.org/licenses/by/4.0/). Data are presented as mean + SEM, **p < 0.01 effect of diet, ****p < 0.0001 effect of diet, ^p < 0.05 effect of dementia, ^^^p < 0.001 effect of dementia, ^^^^p < 0.0001 effect of dementia, 2-way ANOVA, (n = 13–25/group)CC BY · PubMed Central
Fig. 2 HF diet caused a wider array of cognitive impairment in females compared to males. A Episodic-like memory was assessed in the novel object recognition test (NORT). Recognition index (% time spent with the novel object) was calculated. Performance not significantly greater than chance (50%, indicated by the red line) indicates impaired memory. B–D Spatial learning and memory was assessed using the Morris Water Maze (MWM). Five hidden trials (B) assessed spatial learning via pathlength to reach the target platform (shorter pathlength = better performance). Average pathlength over the 5 hidden trials (C) was longer (more impaired memory) in MxD females and AD females on a HF diet. Spatial memory was assessed in the probe trial (D), as % time spent in the target quadrant vs. chance (25%, indicated by the red line). Performance above 25% indicates intact memory. E The nest building task was used to assess activities of daily living. Nests were graded on 1–5 scale (average of scores by 3 experimenters blinded to treatment). Lower scores are indicative of impairment. Data are presented as mean + SEM except for nest building (median + interquartile range), +++p < 0.001 vs chance, +p < 0.05 vs. chance, **p < 0.01 effect of diet, ^p < 0.05 effect of dementia, ^^p < 0.01 effect of dementia, ^^^^p < 0.0001 effect of dementia, Red line = chance, 2-way ANOVA, (n = 5–11/group NOR, n = 8–13/group MWM, nest building)
Fig. 2 HF diet caused a wider array of cognitive impairment in females compared to males. A Episodic-like memory was assessed in the novel object recognition test (NORT). Recognition index (% time spent with the novel object) was calculated. Performance not significantly greater than chance (50%, indicated by the red line) indicates impaired memory. B–D Spatial learning and memory was assessed using the Morris Water Maze (MWM). Five hidden trials (B) assessed spatial learning via pathlength to reach the target platform (shorter pathlength = better performance). Average pathlength over the 5 hidden trials (C) was longer (more impaired memory) in MxD females and AD females on a HF diet. Spatial memory was assessed in the probe trial (D), as % time spent in the target quadrant vs. chance (25%, indicated by the red line). Performance above 25% indicates intact memory. E The nest building task was used to assess activities of daily living. Nests were graded on 1–5 scale (average of scores by 3 experimenters blinded to treatment). Lower scores are indicative of impairment. Data are presented as mean + SEM except for nest building (median + interquartile range), +++p < 0.001 vs chance, +p < 0.05 vs. chance, **p < 0.01 effect of diet, ^p < 0.05 effect of dementia, ^^p < 0.01 effect of dementia, ^^^^p < 0.0001 effect of dementia, Red line = chance, 2-way ANOVA, (n = 5–11/group NOR, n = 8–13/group MWM, nest building)CC BY · PubMed Central
Fig. 3 Astrogliosis is exacerbated in AD/MxD females, while microglia coverage is decreased in AD/MxD males. A Hippocampal regions of interest examined: CA1, CA2, CA3, and the dentate gyrus (image created with BioRender.com). B Microgliosis in the CA1 region of the hippocampus was gauged through Iba1 immunofluorescence (greater % area covered indicating greater microgliosis). C Astrogliosis was gauged through GFAP immunofluorescence (greater % area covered indicating greater astrogliosis). D Representative images of Iba-1 immunofluorescence in the CA1 regions. E Representative images of GFAP immunofluorescence in the CA1 regions. F–H Hippocampal expression of markers for microgliosis (Iba-1: F and CD68: G) and astrogliosis (GFAP: H) normalized to RPL13A expression. Data are presented as mean + SEM, effect of dementia: ^p < 0.05 effect of dementia, ^^^^p < 0.0001 effect of dementia, effect, *p < 0.05 effect of diet, 2-way ANOVA, (n = 4–5/group)
Fig. 3 Astrogliosis is exacerbated in AD/MxD females, while microglia coverage is decreased in AD/MxD males. A Hippocampal regions of interest examined: CA1, CA2, CA3, and the dentate gyrus (image created with BioRender.com). B Microgliosis in the CA1 region of the hippocampus was gauged through Iba1 immunofluorescence (greater % area covered indicating greater microgliosis). C Astrogliosis was gauged through GFAP immunofluorescence (greater % area covered indicating greater astrogliosis). D Representative images of Iba-1 immunofluorescence in the CA1 regions. E Representative images of GFAP immunofluorescence in the CA1 regions. F–H Hippocampal expression of markers for microgliosis (Iba-1: F and CD68: G) and astrogliosis (GFAP: H) normalized to RPL13A expression. Data are presented as mean + SEM, effect of dementia: ^p < 0.05 effect of dementia, ^^^^p < 0.0001 effect of dementia, effect, *p < 0.05 effect of diet, 2-way ANOVA, (n = 4–5/group)CC BY · PubMed Central
Fig. 4 Female AD/MxD mice have greater Aβ, but not tau, pathology. A Representative image of Aβ plaques. B The number of Aβ plaques/brain section (averaged across 8, 40-μM-thick brain sections between -1.46 and -3.52 mm from bregma). C Hippocampal insoluble Aβ-40, measured by ELISA. D Hippocampal insoluble Aβ-42, measured by ELISA. E Representative Western blot images of tau protein in right (ischemic for MxD) hippocampal isolates. Measurements for F total tau, G pTau S199, and H pTauPHF1 were normalized to GAPDH. Data are presented as mean + SEM, #p < 0.05 effect of sex, ##p < 0.01 effect of sex, 3-way ANOVA, (n = 4–5/group)
Fig. 4 Female AD/MxD mice have greater Aβ, but not tau, pathology. A Representative image of Aβ plaques. B The number of Aβ plaques/brain section (averaged across 8, 40-μM-thick brain sections between -1.46 and -3.52 mm from bregma). C Hippocampal insoluble Aβ-40, measured by ELISA. D Hippocampal insoluble Aβ-42, measured by ELISA. E Representative Western blot images of tau protein in right (ischemic for MxD) hippocampal isolates. Measurements for F total tau, G pTau S199, and H pTauPHF1 were normalized to GAPDH. Data are presented as mean + SEM, #p < 0.05 effect of sex, ##p < 0.01 effect of sex, 3-way ANOVA, (n = 4–5/group)CC BY · PubMed Central
Fig. 5 Cognitive impairments and pathological outcomes are correlated with metabolic deficits in male and female mice. Using a correlation matrix, we compared relationships between cognitive, metabolic, and pathological factors. A, B Correlations between cognitive and metabolic measures. Visc fat: visceral fat pad weight normalized to body weight (n = 55–58/sex); AUC: area under the curve from the glucose tolerance test, high AUC indicates greater glucose intolerance (n = 54–58/sex); %decrease in blood flow: the percent difference in cerebral blood flow in the temporal region of the cortical brain surface (n = 50–51/sex); MWM % target: % of the time spent in the target quadrant of the probe trial of the MWM test, higher percentage indicates better spatial memory (n = 58/sex); NOR% time: % time spent with the novel object in the testing trial of the NOR test, higher percentage indicates better episodic-like memory (n = 46–49/sex); ADLs: activities of daily living assessed by score in the nest building test, a lower score indicates worse ADLs (n = 57–58/sex). C, D Correlations between metabolic and pathological measures in the subset of mice designated for IHC. AUC: area under the curve from the glucose tolerance test, high AUC indicates greater glucose intolerance (n = 18–21/sex); amyloid count: the number of cells in a cortical ROI that were positive for beta-amyloid (n = 19–20/sex); CA1 GFAP: the % area covered by GFAP staining in the CA1 region of the hippocampus, greater coverage indicates greater astrogliosis in that region (n = 18–19/sex); CA2 GFAP, (n = 17–19/sex); CA1 Iba2: the % area covered by Iba1 staining in the CA1 region of the hippocampus, greater coverage indicates greater astrogliosis (n = 17–18/sex) CA2 Iba1, (n = 18/sex). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, significant correlation; Pearson r values are presented. Yellow: positive correlation, Blue: negative correlation. E, F Linear regression of CA1 Iba1% area covered and glucose tolerance test from the AUC (males: n = 19; females n = 17). r2 value and p value are presented
Fig. 5 Cognitive impairments and pathological outcomes are correlated with metabolic deficits in male and female mice. Using a correlation matrix, we compared relationships between cognitive, metabolic, and pathological factors. A, B Correlations between cognitive and metabolic measures. Visc fat: visceral fat pad weight normalized to body weight (n = 55–58/sex); AUC: area under the curve from the glucose tolerance test, high AUC indicates greater glucose intolerance (n = 54–58/sex); %decrease in blood flow: the percent difference in cerebral blood flow in the temporal region of the cortical brain surface (n = 50–51/sex); MWM % target: % of the time spent in the target quadrant of the probe trial of the MWM test, higher percentage indicates better spatial memory (n = 58/sex); NOR% time: % time spent with the novel object in the testing trial of the NOR test, higher percentage indicates better episodic-like memory (n = 46–49/sex); ADLs: activities of daily living assessed by score in the nest building test, a lower score indicates worse ADLs (n = 57–58/sex). C, D Correlations between metabolic and pathological measures in the subset of mice designated for IHC. AUC: area under the curve from the glucose tolerance test, high AUC indicates greater glucose intolerance (n = 18–21/sex); amyloid count: the number of cells in a cortical ROI that were positive for beta-amyloid (n = 19–20/sex); CA1 GFAP: the % area covered by GFAP staining in the CA1 region of the hippocampus, greater coverage indicates greater astrogliosis in that region (n = 18–19/sex); CA2 GFAP, (n = 17–19/sex); CA1 Iba2: the % area covered by Iba1 staining in the CA1 region of the hippocampus, greater coverage indicates greater astrogliosis (n = 17–18/sex) CA2 Iba1, (n = 18/sex). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, significant correlation; Pearson r values are presented. Yellow: positive correlation, Blue: negative correlation. E, F Linear regression of CA1 Iba1% area covered and glucose tolerance test from the AUC (males: n = 19; females n = 17). r2 value and p value are presentedCC BY · PubMed Central
Fig. 6 Summary of our major findings. We demonstrate relative accumulation of cognitive impairments and neuropathology of female male (left, blue) and (right, pink) mice along a center scale with the top of the scale indicating less impairment and pathology and the bottom of the scale representing greater impairment and pathology
Fig. 6 Summary of our major findings. We demonstrate relative accumulation of cognitive impairments and neuropathology of female male (left, blue) and (right, pink) mice along a center scale with the top of the scale indicating less impairment and pathology and the bottom of the scale representing greater impairment and pathologyCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 105 references

Research works printed but not linked: 2

  1. Javonillo DI, Tran KM, Phan J, Hingco E, Kramár EA, da Cunha C, et al. Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer’s Disease. Front Neurosci. 2021;15: 785276. · DOI · Paper page
  2. Zuloaga KL, Johnson LA, Roese NE, Marzulla T, Zhang W, Nie X, et al. High fat diet-induced diabetes in mice exacerbates cognitive deficit due to chronic hypoperfusion. J Cerebral Blood Flow Metab. 2016;36(7):1257–70. · DOI

Cited by

See all 130

Metadata

Authors
Gannon, O. J., Robison, L. S., Salinero, A. E., Abi-Ghanem, C., Mansour, F. M., Kelly, R. D., Tyagi, A., Brawley, R. R., Ogg, J. D., & Zuloaga, K. L.
Affiliations
  • Albany Medical College (US)
  • Nova Southeastern University (US)
  • Stetson University (US)
Corresponding author
Zuloaga, Kristen L.
Venue
Journal of Neuroinflammation
Published
2022-05-14
Volume
19
Issue
1
Pages
110-110
ISSN
1742-2094 (ISSN-L)
OpenAlex
W4280628531
Cited by
127
References
104
Citations by year
2026: 21 · 2025: 33 · 2024: 41 · 2023: 24 · 2022: 8
FWCI
9.48
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • American Heart Association (16SDG27190001, 20PRE35080166)
  • National Institute of Neurological Disorders and Stroke (R01NS110749, F31 NS115290)
  • National Institute on Aging (U01AG072464)
  • Albany Medical College startup funds
Topics
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, mixed dementia, high-fat diet, prediabetes, sex differences, cognitive decline, 3xTg-AD mice, common carotid artery occlusion, cerebral hypoperfusion, spatial memory, astrocyte activation, microglial activation, amyloid plaques, impaired glucose tolerance
MeSH terms
Activities of Daily Living, Alzheimer Disease, Animals, Disease Models, Animal, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Prediabetic State, Dementia, Vascular, Amyloid beta-Peptides, Mice, Plaque, Amyloid, Diet, High-Fat, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High-fat diet exacerbates cognitive decline in mouse models of Alzheimer's disease and mixed dementia in a sex-dependent manner. https://app.cochat.ai/papers/10.1186/s12974-022-02466-2
The paper
Gannon, O. J., Robison, L. S., Salinero, A. E., Abi-Ghanem, C., Mansour, F. M., Kelly, R. D., Tyagi, A., Brawley, R. R., Ogg, J. D., & Zuloaga, K. L. (2022). High-fat diet exacerbates cognitive decline in mouse models of Alzheimer's disease and mixed dementia in a sex-dependent manner. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-022-02466-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.